Co-Founder
CurrentCellarisBio provides drug discovery solutions to biotech companies working on targeted therapies. Patent-pending drug-target engagement technology enables discovery, validation, and optimization of different therapeutic modalities to challenging drug targets in the physiological environment of the cell.